Gaso
Gasoroil,
Perhaps it would be better if you are to go and read what is written in page 14 of the Interim Financial Report dated 31st of December 2017 before writing what you did.
Shock horror if you do mate.
-----------------------------------------------------
2017 2016
$ $
Operating revenue 17,673,716 12,639,411
Cost of sales (8,996,266) (7,899,120)
Gross profit 8,677,450 4,740,291
Other income 4 530,059 1,021,112
Share based employment benefits (1,049,130) (1,138,885)
General and administrative expenses (358,261) (257,662)
Depreciation and amortisation (4,021,100) (3,849,344)
Employee benefits and associated costs (1,647,626) (2,143,840)
Exploration expenditure (1,704,973) (576,568)
Finance costs (4,345,047) (3,941,567)
Loss before income tax (3,918,628) (6,146,463)
Income tax credit - -
Loss for the half-year (3,918,628) (6,146,463)
Other comprehensive loss for the half-year, net of tax - -
Total comprehensive loss for the half-year (3,918,628) (6,146,463
- Forums
- ASX - By Stock
- CTP
- True to form
CTP
central petroleum limited
Add to My Watchlist
1.85%
!
5.5¢

True to form, page-48
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.5¢ |
Change
0.001(1.85%) |
Mkt cap ! $40.98M |
Open | High | Low | Value | Volume |
5.4¢ | 5.5¢ | 5.4¢ | $91.62K | 1.696M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 449381 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.8¢ | 6030 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 449381 | 0.054 |
1 | 100000 | 0.053 |
3 | 719000 | 0.052 |
1 | 800000 | 0.051 |
2 | 39000 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.058 | 6030 | 1 |
0.059 | 379120 | 4 |
0.060 | 160000 | 3 |
0.061 | 100000 | 1 |
0.067 | 149268 | 1 |
Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
Featured News
CTP (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online